News Releases
- May 22, 2014
- Tocagen announces presentations at ASGCT and ASCO annual conferences
- April 10, 2014
- Tocagen Clinical Data Presented at AANS Annual Conference
- March 25, 2014
- Tocagen Names Jamey Skillings, M.D., Chief Medical Officer
- March 11, 2014
- Tocagen Announces Dosing of First Patient In Intravenous Study
- November 26, 2013
- Tocagen Announces Data Presentations at SNO conference
- August 6, 2013
- Southern California’s First Real-Time MRI-Guided Gene Therapy for Brain Cancer at UC San Diego Health System
- June 19, 2013
- VABC Awards Grant to Tocagen
- May 30, 2013
- Advancing Neuroscience: MRI Interventions, IMRIS and Tocagen Combine Technologies to Precisely Deliver Potential Cancer-Fighting Drug to Brain Tumors
- July 17, 2012
- Musella Foundation Awards Grant to Tocagen
- February 7, 2012
- Tocagen Forms Diagnostics Partnership with Siemens
- February 3, 2012
- Study Published in Neuro-Oncology Journal Shows Brain Tumor Eradication and Prolonged Survival in Mice Treated With Toca 511 and 5-FC
- June 7, 2011
- Tocagen Announces First-in-Human Clinical Trial in Brain Cancer
- May 10, 2011
- American Brain Tumor Association Awards Clinical Research Grant to Tocagen
- August 5, 2010
- NBTS Awards Research Grant for GBM Brain Cancer to Tocagen
- October 26, 2009
- Accelerate Brain Cancer Cure (ABC2) Awards Grant to Tocagen Inc.
Articles
Videos
- August 9, 2013
Tocagen Featured on KPBS Interview - August 8, 2013
Tocagen Featured on NBC News - March 22, 2012
Tocagen Featured on CBS News
Toca 511 infusion in patient with brain cancer at UCSF using real-time MRI guidance
NBC affiliate features Cleveland Clinic patient in Tocagen’s investigational trial for brain cancer
CBS News features Tocagen’s Clinical Trial for Brain Cancer at JFK
Toca 511 Presentation by Michael Vogelbaum, MD., Ph.D. Cleveland Clinic Foundation